BBGBloomberg·1hBusiness
score-0.60
Investors Assess Moderna and Merck Melanoma Vaccine Data, Prompting Share Decline
Original
Moderna, Merck Fall After Melanoma Data Leak
“Negative financial framing using 'plummeted' and 'leak' emphasizes market disappointment and data inadequacy.”